In an open study, a total of 18 patients with proven bullous pemphigoid (16 new patients and two in relapse) were treated with a trial of dapsone (17 patients) or sulphonimide (one patient). Overall, eight patients were controlled on one of these agents as the sole treatment (44%). Six patients had a partial, but inadequate response, while four did not respond. The responses to the sulpha drugs were generally rapid, i.e. within 2 weeks, and the maximum doses used in any patient were 100 mg/da...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Dapsone as first line therapy for bullous pemphigoid.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record